Xeris Biopharma Quote - 0A8E

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

Bid

0.00

Offer

0.00

Volume

368

0.00 Day's Range 0.00

0.00 52 Week Range 0.00

Market Cap

Previous Close

0.00

Open

Last Trade

3.7139

(O)

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

Shares Outstanding

138,125,000

Dividend Yield

PE Ratio

-8.10

Earnings Per Share (EPS)

-0.45

Revenue

163.91M

Net Profit

-62.26M

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.xerispharma.com

Headquarters

Wilmington, Delaware, USA

Founded

Xeris Biopharma Inc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker 0A8E. The last closing price for Xeris Biopharma was US$0. Over the last year, Xeris Biopharma shares have traded in a share price range of US$ 0.00 to US$ 0.00.

Xeris Biopharma currently has 138,125,000 shares in issue. Xeris Biopharma has a price to earnings ratio (PE ratio) of -8.10.

J.P. Morgan Securities LLC Xeris Pharmaceuticals, Inc 8.3

J.P. Morgan Securities LLC 07 October 2021 Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH...

J.P. Morgan Securities LLC Xeris Pharmaceuticals, Inc 8.3

J.P. Morgan Securities LLC 06 October 2021 Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH...

Lazard Asset Management Form 8.3 - Xeris Pharmaceuticals, Inc

Lazard Asset Management 06 October 2021 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS...

J.P. Morgan Securities LLC Xeris Pharmaceuticals, Inc 8.3 Amend

J.P. Morgan Securities LLC 05 October 2021 Ap19 AMENDMENT FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY...

J.P. Morgan Securities LLC Xeris Pharmaceuticals, Inc 8.3

J.P. Morgan Securities LLC 05 October 2021 Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH...

J.P. Morgan Securities LLC Xeris Pharmaceuticals, Inc 8.3

J.P. Morgan Securities LLC 04 October 2021 Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH...

J.P. Morgan Securities LLC Xeris Pharmaceuticals, Inc 8.3

J.P. Morgan Securities LLC 01 October 2021 Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH...

Morgan Stanley Smith Barney LLC Form 8.3 - XERIS PHARMACEUTICALS INC

Morgan Stanley Smith Barney LLC 01 October 2021 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH...

J.P. Morgan Securities LLC Xeris Pharmaceuticals, Inc 8.3

J.P. Morgan Securities LLC 30 September 2021 Ap19 AMENDMENT FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY...

J.P. Morgan Securities LLC Xeris Pharmaceuticals, Inc 8.3

J.P. Morgan Securities LLC 30 September 2021 Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

0A8E - Frequently Asked Questions (FAQ)

What is the current Xeris Biopharma share price?

The current share price of Xeris Biopharma is US$ 0.00

How many Xeris Biopharma shares are in issue?

Xeris Biopharma has 138,125,000 shares in issue

What is the 1 year trading range for Xeris Biopharma share price?

Xeris Biopharma has traded in the range of US$ 0.00 to US$ 0.00 during the past year

What is the PE ratio of Xeris Biopharma?

The price to earnings ratio of Xeris Biopharma is -8.1

What is the cash to sales ratio of Xeris Biopharma?

The cash to sales ratio of Xeris Biopharma is 3.08

What is the reporting currency for Xeris Biopharma?

Xeris Biopharma reports financial results in USD

What is the latest annual turnover for Xeris Biopharma?

The latest annual turnover of Xeris Biopharma is USD 163.91M

What is the latest annual profit for Xeris Biopharma?

The latest annual profit of Xeris Biopharma is USD -62.26M

What is the registered address of Xeris Biopharma?

The registered address for Xeris Biopharma is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the Xeris Biopharma website address?

The website address for Xeris Biopharma is www.xerispharma.com

Which industry sector does Xeris Biopharma operate in?

Xeris Biopharma operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
GILDGuild Esports Plc	0.075p (66.67%)	158.2M
MSMNMosman Oil And Gas Limited	0.038p (52.00%)	2.3B
MODER8 Capital Investments Plc	2.10p (40.00%)	7.75M
LENDSancus Lending Group Limited	0.60p (33.33%)	2.2M
KMKKromek Group Plc	6.65p (25.47%)	41.88M
FUMFutura Medical Plc	16.98p (-45.23%)	8.72M
RCDORicardo Plc	263.00p (-25.28%)	4.42M
PEGPetards Group Plc	6.50p (-18.75%)	1.16M
SCGLSealand Capital Galaxy Limited	6.50p (-14.47%)	6.21M
SIVSivota Plc	3.00p (-14.29%)	7.5k
MSMNMosman Oil And Gas Limited	0.038p (52.00%)	2.3B
DKEDukemount Capital Plc	0.055p (22.22%)	1.4B
EMEEmpyrean Energy Plc	0.115p (4.55%)	917.03M
TRPTower Resources Plc	0.0295p (3.51%)	470.89M
DGIDg Innovate Plc	0.0155p (-8.82%)	344.08M